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A B S T R A C T
Hydrogels based on natural polymers oﬀer a range of properties to mimic the native extracellular matrix, and
provide microenvironments to preserve cellular function and encourage tissue formation. A tri-component hy-
drogel using collagen, alginate and ﬁbrin (CAF) was developed and investigated at three collagen concentrations
for application as a functional extracellular matrix analogue. Physical-chemical characterization of CAF hy-
drogels demonstrated a thermo-responsive crosslinking capacity at physiological conditions with stiﬀness similar
to native soft tissues. CAF hydrogels were also assessed for cytocompatibility using L929 murine ﬁbroblasts,
pancreatic MIN6 β-cells and human mesenchymal stem cells (hMSCs); and demonstrated good cell viability,
proliferation and metabolic activity after 7 days of in vitro culture. CAF hydrogels, especially with 2.5% w/v
collagen, increased alkaline phosphatase production in hMSCs indicating potential for the promotion of osteo-
genic activity. Moreover, CAF hydrogels also increased metabolic activity of MIN6 β-cells and promoted the
reconstitution of spherical pseudoislets with sizes ranging between 50 and 150 μm at day 7, demonstrating
potential in diabetic therapeutic applications.
1. Introduction
To date, biomaterials for regenerative medicine applications have
primarily focused on controlling cell function and lineage commitment
[1,2]. These materials can be tailored to provide a tissue-speciﬁc bio-
mimetic microenvironment for cell housing and protection from hostile
environment and immune-attack prior to engraftment; improving ad-
hesion, viability and function. Hydrogels are hydrated biomaterials
capable of suspending cells at targeted sites for cell engraftment [2,3],
with control of permeability and mechanical properties possible
through modulating the viscosity. Polymeric hydrogels have become
attractive extracellular matrix (ECM) substitutes for biomedical appli-
cations due to their speciﬁc combination of biocompatibility, biode-
gradability, the “tunability” of mechanical properties, biomimicry,
modularity, and responsiveness, as well as their innate ability to retain
large amounts of water, promoting cell health [2,4,5]. For this reason,
hydrogels based on natural polymers oﬀer a versatile platform to en-
gineer diverse combinations of properties to mimic features of native
ECM and to provide spatial support and access to functional moieties
such as RGD, to preserve cellular functions and encourage tissue for-
mation [6–9]. Many of these materials are designed to be delivered
using minimally invasive techniques, with the aim to create complex
structures and organizations via extrusion processes involving catheters
or syringes [10–12]. Versatile hydrogels allows to bioengineer 3D cell
culture studies, including cellular organization into organoids and
tissue formation ex vivo, for developing great new models for drug
detection and tissue regeneration in the clinic [13,14].
Collagen is the main structural protein for most tissues and is able to
self-assemble into ﬁbril structures under physiological conditions. This
makes it an ideal component in engineered tissues as it can impart
mechanical properties to otherwise amorphous hydrogels; which can be
modulated to mimic native tissues [15–17]. It provides ready access to
several key recognition sites for cellular migration and attachment, as
well as providing long-term structural support to tissues [18]. Alginate
is a readily available natural biopolymer, which provides good long-
time stability, can be puriﬁed to prevent immunogenicity [18], and is
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able to absorb large amount of aqueous biological ﬂuids [19,20]. Fibrin
is also a native biopolymer, formed physiologically during blood coa-
gulation, which has a critical role in haemostasis and tissue repair,
stimulating wound healing and thus encouraging implant engraftment
[21,22]. Like collagen, ﬁbrin possesses several key amino acid binding
sequences, including two pairs of RGD sites involved in cell-integrin
interactions [21]. These materials can be tailored to provide a tissue-
speciﬁc biomimetic microenvironment for cell housing, improving in
situ retention and viability, while simultaneously providing protection
from potentially hostile environments such as those found in injured or
diseased tissues [5,23,24].
A variety hydrogels have been formulated by using these biopoly-
mers and derivatives (i.e. alginate, gelatin, ﬁbrin, collagen, etc.) as
encapsulation systems, microﬂuidic hydrogels, injectable materials, cell
delivery systems, scaﬀolds, and as bioink for biofabrication [25,26].
Alginate-ﬁbrin hydrogels have demonstrated the ability to induce in
vitro osteogenic diﬀerentiation of adipose stem cells [27]; enable fast
release of stem-cells when used as a stem-cell encapsulation system
[28]; support chondrogenesis of bone-derived mesenchymal stems cell
[29]; and support in vitro development of caprine preantral follicles
[30]. Similar hydrogels systems have also incorporated gelatin for
fabricating tubular constructs similar to blood vessels [31], biomimetic
scaﬀolds for cartilage regeneration [32], in vitro physiological models
of the metabolic syndrome [25], and aortic valve conduits by 3D bio-
printing [33]. Gelatin is the denaturated version of the collagen protein,
thus several important biological and physical-chemical properties
diﬀer between the two biopolymers including gelation temperatures
[34] and cellular binding mechanisms [35]. While various studies have
shown the advantages and application of hydrogels combinations such
as collagen-alginate [36–38], ﬁbrinogen-alginate [29,39,40] and col-
lagen-ﬁbrinogen [41,42] hydrogels; the formulation of collagen-ﬁ-
brinogen-alginate into a tri-component hydrogel, potentially combining
the beneﬁts of all three components, has not been explored before.
Here we describe the formulation and characterization of a new
thermo-responsive hydrogel inspired by native ECM that integrates the
excellent biological properties of collagen as an extracellular matrix
structural protein, ﬁbrin as a natural regulator of haemostasis and tissue
repair, and alginate for controlled protein release. While collagen has
been widely used as hydrogel for tissue engineering applications
[43–48], the use of collagen combined with alginate and ﬁbrin has not
previously been investigated. A new synthesis scheme is described and
was used to create three diﬀerent collagen concentrations, which were
characterized to determine physical-chemical properties and cellular
response. Biological potential of formulated CAF hydrogels hold for soft
tissue engineering applications, particularly musculoskeletal and pan-
creatic applications, is demonstrated by using three diﬀerent cell types:
murine ﬁbroblasts (L929), murine pancreatic β-cells (MIN6) and
human-TERT mesenchymal stem cells (Y201 hMSCs) [49].
2. Materials and methods
2.1. Materials
Type I collagen from calf skin (Sigma Aldrich, C9791-250MG), al-
ginic acid sodium salt from brown algae - low viscosity (Sigma, A1112 –
100G), ﬁbrinogen from bovine plasma (Sigma, F8630 - 1G), thrombin
from bovine plasma (Sigma, T4648 – 1KU), (2%, v/v) acetic acid
(Sigma Aldrich, A6283), NaOH (1M), Dulbecco's Modiﬁed Eagle's
Medium (Sigma, DMEM – 500 ML), Phosphate Buﬀered Saline (PBS)
(Sigma Aldrich, PBS1).
2.2. Methods
2.2.1. Collagen-Alginate-Fibrin (CAF) hydrogel preparation
Collagen solutions were prepared at three concentrations, 0.5%, 1%
and 2.5% w/v, by dissolving collagen powder in 2% v/v acetic acid at
4 °C. Once dissolved, the pH of the collagen solutions was adjusted to
5.5–6. A 5% alginate solution was prepared by dissolving alginic acid
sodium salt powder in sterile calcium free PBS and pasteurized by in-
cubation at 70 °C for 20min and allowed to cool down to room tem-
perature. This process was repeated three times. The solution was then
slowly stirred until fully dispersed, to obtain a viscous solution. 10% w/
v ﬁbrinogen solution was obtained by dissolving ﬁbrinogen powder in
sterile PBS solution, and ﬁltered using a 0.22 μm ﬁlter. Alginate and
ﬁbrinogen solutions were then mixed at a 1:1 ratio. Then, the collagen
solution was added to the alginate/ﬁbrinogen mixture so that a volume
ratio of 2:1:1 (collagen solution: alginate solution: ﬁbrin solution) was
obtained, and the mixture stirred until homogenous. The pH of the CAF
solution was then adjusted to 7.4. CAF hydrogels were then formed by
polymerizing the single components in the mixture, as follows: 1) col-
lagen gelation was induced by increasing the temperature to 37 °C in an
incubator, until a self-contained gel is formed; then 2) alginic acid was
polymerized by calcium diﬀusion through the gel by using 10% w/v of
CaCl2 in distilled water for 1min; 3) the CAF gel was then incubated for
15min in a 1 U/mL of thrombin solution prepared by dissolving
thrombin powder in PBS containing 0.1% FBS in order to polymerize
ﬁbrinogen into ﬁbrin. Before use the CaCl2 and thrombin were ﬁltered
using a 0.22 μm ﬁlter.
2.3. Characterization methods
2.3.1. Attenuated Total Reﬂection Fourier Transform Infrared Spectroscopy
(ATR-FTIR)
PerkinElmer UATR-Two, equipped with diamond total reﬂectance
(ATR) crystal and PerkinElmer Spectrum Software analyse the chemical
composition of freeze-dried hydrogels in the range of 550–4000 cm−1
at a resolution of 4 cm−1 and 32 scans.
2.3.2. Scanning Electron Microscopy (SEM)
Hydrogel samples were frozen in liquid nitrogen and freeze-dried
using an ALPHA 1–2 LD plus freeze-dryer, at 0.060mbar for 48 h. The
CAF hydrogels were studied using a low vacuum SEM (Hitachi TM
3030), with an accelerating voltage of 15 kV. Pore sizes were measured
from the SEM images (n= 4 samples) using ImageJ software (National
Institutes of Health, USA).
2.3.3. Transmission electron microscopy (TEM)
Hydrogels samples were ﬁxed overnight in 2.5% glutaraldehyde at
4 °C. Then, samples were post-ﬁxed treated with 0.5% OsO4. Images
were obtained after samples were embedded in resin and sectioned,
using a Philips CM100 Transmission EM at HV=100.0 kV and a range
of magniﬁcations up to 130,000×.
2.3.4. Gelation time
The gelation time was assessed using the “vial tilt” method. Vials
(n= 5) were ﬁlled with 1mL of 0.5%, 1% and 2.5% CAF hydrogel and
incubated at 37 °C. Samples were then tilted every 5min and classiﬁed
as either a solution or gel.
2.3.5. Equilibrium swelling
Freeze-dried hydrogels were immersed in sealed vials containing
phosphate buﬀer saline (PBS). After 24 h of incubation, the samples
were removed from the vials and weighed (Ww), removing any excess
water with ﬁlter paper. The equilibrium swelling of each hydrogel was
calculated from:
= − ×Swelling (%) [(W W )/W ] 100w d d (1)
where, Ww and Wd were the weights of the hydrogels at the swelling
state and dry state, respectively. All measurements were performed in
triplicate.
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2.3.6. Hydrolytic degradation
Hydrogel disks of 7mm diameter and 2mm thickness were in-
cubated in 48 well-plates with 1mL of low glucose Dulbecco's Modiﬁed
Eagle's Medium (DMEM) at 37 °C under agitation at 35 rpm using
Stackable Shakers (ThermoScientiﬁc MaxQ6000). Culture media was
changed every three days and samples were measured gravimetrically
after 0 h, 24 h, 3 days, 5 days, 8 days, 10 days, 14 days of incubation by
carefully removing any excess water with ﬁlter paper and weighing
each sample. All experiments were performed in triplicate.
2.3.7. Enzymatic degradation
Enzymatic degradation was performed according to protocols de-
veloped for tissue dissociation [50] using Collagenase NBTM (SERVA
Electrophoresis GmbH). Brieﬂy, 8.1 U/mL Clostridium histolyticum
collagenase was dissolved in Hank's Balanced Salt Solution (HBSS) with
0.169 U/mL neutral protease from Clostridium histolyticum and 2mM
CaCl2, in order to obtain a ﬁnal collagenase dose of 21 U/g collagenase
and 0.43 U/g neutral protease to degrade each CAF sample. Samples
were incubated at 37 °C and visualized after 15min, 30min, 1 h, 2 h
and 3 h. Samples immersed in PBS were used as a negative control. Each
test was performed in triplicate.
2.3.8. Rheology analysis
Rheological characterization was performed using a Kinexus
Rotational Rheometer (Malvern Instruments Ltd., UK) with 20mm
diameter serrated plates. A special solvent trap system was used to
prevent dehydration of the sample during the tests. To identify the
linear viscoelastic region (LVR), oscillatory strain sweep tests were
applied between 0.01% and 100%. Frequency sweep tests
(0.001–10 Hz) were performed at a strain of 0.1% which was within
LVR, to study how the elastic modulus (G′), viscous modulus (G″) and
viscosity (η) changed with frequency. All tests were done at physiolo-
gical temperature (37 °C). At least three replicates were used for each
test.
2.3.9. Cytocompatibility tests
Cells were cultured at 37 °C and 5% CO2 in a humidiﬁed incubator
using DMEM™ (Dulbecco's Modiﬁed Eagle Medium) basal medium,
with high-glucose DMEM™ (Gibco) used for the L929 murine ﬁbroblasts
and MIN6 pancreatic beta cells, and low-glucose for the human TERT
(Y201) human mesenchymal stem cells. In all cases the basal media was
supplemented with 10% FBS, 1% penicillin-streptomycin, with the
MIN6 culture medium also supplemented with 25mM HEPES and
70 μM beta-mercaptoethanol. The hydrogel substrates were placed into
Millicell® 24-well culture plates, with diﬀerent cell populations then
seeded dependent on the cell type: 2× 103 L929 cells per well;
1.6× 105 MIN6 cells per well; and 5×103 Y201 cells per well. In each
case the positive control was the same number of cells seeded on tissue
culture plastic, and gels without cells were used as the negative control.
2.3.9.1. DNA quantiﬁcation. Cellular viability was quantiﬁed by
measuring the DNA content of cells seeded on the hydrogels using the
Quanti-iTTM Picogreen® dsDNA assay kit. DNase/RNase-free water was
added to each sample and samples were freeze-thawed three times to
ensure the complete lysis of the cells. 100 μL of the lysates and 100 μL of
the PicoGreen solution (prepared according to the manufacturer's
protocol) were added to each well of a 96-well plate. Fluorescence
was measured at 480 nm excitation and 520 nm emission using a
FLUOstar OPTIMA microplate reader. A standard curve of DNA was
produced using known concentrations of lambda DNA (Invitrogen).
2.3.9.2. Live-dead staining assay. L3224 Live/Dead assay (Life
Technologies, UK), in brief, 4 μM ethidium homodimer-1 and 10 μM
calcein in PBS were incubated in the dark with the cell-seeded CAF
samples for 30min at 37 °C. Samples were imaged immediately using a
Nikon A1R inverted confocal microscope. Stained areas were quantiﬁed
using ImageJ software (National Institutes of Health, USA).
2.3.9.3. Metabolic activity. Quantiﬁed by normalizing results from the
PrestoBlue™ assay (Invitrogen, UK) to the corresponding DNA content
measured with PicoGreen™, as described above. Culture medium was
aspirated and samples were washed with pre-warmed PBS at 37 °C. 10%
PrestoBlue™ working solution in culture medium was transferred to
wells of a 96 well plate. Samples were incubated at 37 °C, 5% CO2 for
the following durations: 1.5 h for L929, 2 h for Y201 hMSCs and 24 h for
MIN6. 100 μL of the PrestoBlue™ solution from each well was assessed
in triplicate with the ﬂuorescence measured at 560 nm excitation and
590 nm emission.
2.3.9.4. Cellular morphology analysis. The morphology of the cells was
observed by staining their cytoskeleton using rhodamine-phalloidin and
the nucleus observed using DAPI. After the culture period, samples
were ﬁxed in 4% paraformaldehyde for 15min and washed three times
with PBS. Cells were permeabilised using 0.1% v/v Tween20® in PBS
for 5min. Rhodamine-phalloidin was prepared using 1:100 dilutions of
phalloidin-tetramethylrhodamine B isothiocyanate (P1951) in 1% v/v
Tween20® for 30min. Residue of phalloidin-rhodamine was removed
by washing samples with 1% v/v Tween20® solution. Samples were
immersed in DAPI solution (1mg/mL) and were imaged using a Nikon
A1R inverted confocal microscope.
2.4. Statistical analysis
Data was presented as mean values, standard deviations and/or
standard error. Mean values were calculated from three independent
experiments of triplicates by group. Statistical analysis was performed
by two-way ANOVA followed by Bonferroni Post-hoc tests in GraphPad
Prism™ 6 software using a level of signiﬁcance of p < 0.1 (*),
p < 0.05 (**), p < 0.001 (***) and p < 0.0001(****).
3. Results
3.1. Synthesis and physic-chemical characterization of CAF hydrogels
The main IR peaks attributed to ﬁbrin and collagen were detected in
all three formulations (Fig. 1). These bands are mostly associated with
the amide groups present in both proteins. The bands for collagen and
ﬁbrin shown in Fig. 1.A and B, are mainly at ∼1652–1638 cm−1
(amide I, C]O stretching), ∼1552–1540 cm−1 (amide II, NeH
bending),∼1333–1312 cm−1 and∼1240–1224 cm−1 (amide III, NeH
bending and CeN stretching). These bands (amide I, II and III) were
detected in all three spectra of hydrogels and reported in Fig. 1.B.
Spectral changes on amide I and II were identiﬁed for hydrogels pre-
pared with diﬀerent collagen concentrations. C]O stretching of amide
I and NeH bending of amide II in hydrogels were slightly shifted to
lower frequencies by increasing collagen concentrations. NeH and CeN
bending of amide III for the three hydrogels peaks was found within the
range of both the characteristic collagen and ﬁbrin bands. The C]O
symmetric stretching of COOe at 1418 cm−1 was found in all three
hydrogels, as well as a sharp peak at 1025 cm−1 related to CO, COC and
CC stretching. The characteristic peaks of alginate, C]O symmetric
stretching of COOe were found in all hydrogels and shifted to lower
frequencies by increasing collagen concentration. The spectrum for the
2.5% w/v collagen was closer to the characteristic peak for C]O, in-
dicating symmetric stretching of COOe of collagen.
SEM and image analysis showed pore sizes in the range of
40–120 μm for all three hydrogels (Fig. 2.A). As the collagen con-
centration increased, more closed and less interconnected pores were
observed. TEM (Fig. 2.B) showed a dense protein network was formed
in all samples, with freely organized ﬁbrillary structures. These struc-
tures became more compact and dense with increasing collagen con-
centration. Interestingly, the thickest ﬁbres were observed in 1%
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collagen samples.
The gelation time, swelling, stability and hydrolytic/enzymatic de-
gradation properties of the CAF hydrogels are summarized in Fig. 3.
Gelation time deﬁned as the sol-gel transition of the 0.5%, 1% and 2.5%
collagen hydrogels was determined by using the “vial tilt” method. All
formulations formed self-supporting hydrogels (Fig. 3.A), however the
time at which the inverted solution no longer ﬂowed was found de-
pendent of temperature and collagen concentrations. Gelation of hy-
drogels happened when temperature was increased to 37 °C, and gela-
tion time was reduced as collagen concentration increased ranging from
40 ± 5min for the 2.5% collagen concentration to 60 ± 10min for
the 0.5% collagen concentration. Once the gel was fully formed, the
hydrogel was then stabilized by polymerizing the alginate and ﬁ-
brinogen components with CaCl2 and thrombin, respectively. The
swelling ratios (Fig. 3.B) generally decreased with increasing collagen
content, however the diﬀerences were not statistically signiﬁcant.
Fig. 3.C demonstrates that hydrogels made with 1% and 2.5% collagen
maintained their mass and morphology for 15 days, while the 0.5%
collagen hydrogels demonstrated a sharp loss of mass at day 7.
Collagenase-based enzymatic degradation of the three CAF hydro-
gels was much more rapid than hydrolytic degradation (Fig. 3.D). All
hydrogels remained stable when incubated in collagenase solution for
Fig. 1. FTIR of synthesized CAF hydrogels produced with diﬀerent collagen concentrations: A. IR absorbance spectra, and B. IR characteristic peaks.
Fig. 2. Microstructure and organization: A. SEM and B.TEM of CAF hydrogel at 0.5% w/v, 1% w/v, and 2.5% w/v collagen concentration.
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30min at 37 °C. However, after 30min, the onset of degradation was
observed in the 0.5% collagen hydrogel samples. Degradation was more
obvious after one hour in the 1% and 2.5% collagen hydrogel samples,
but the morphology of samples was maintained. Following 2 h in-
cubation, all three hydrogels were mostly dissolved. Three hours post-
incubation, all hydrogels were completely dissolved in the collagenase
solution with residual debris dispersed in the solution. CAF samples
incubated in PBS did not exhibit any degradation within the 3-hour test
period (data not shown).
Fig. 4 shows the rheological properties of CAF hydrogels. Across all
test conditions, the 2.5% collagen formulation was slightly less than
twice as stiﬀ as the 1% collagen formulation, which was approximately
twice as stiﬀ as the 0.5% collagen formulation. Fig. 4.A shows how the
elastic moduli (G′) of samples changed with increasing shear strain (γ*).
Elastic moduli for all samples remained stable until the shear strain
reached 1%, with moduli of 5 kPa, 2.9 kPa and 1.4 kPa for the 2.5%, 1%
and 0.5% collagen formulations, respectively. Beyond this strain, elastic
moduli gradually decreased due to breakdown of the internal hydrogel
structure. Fig. 4.B–D displays how the elastic moduli (G′), viscous
moduli (G″) and viscosity (η*) of diﬀerent samples change with
Fig. 3. A. Thermo-responsive CAF hydrogels at 37 °C, B. Rate of hydrogel swelling, C. Hydrolytic degradation (2.5% green, 1% red, 0.5% blue) and, D. Enzymatic
degradation with collagenase. Data represent mean values ± SD (n=3), signiﬁcance threshold (*p < 0.1) after two-way ANOVA with Bonferroni Post-hoc test
relative to initial mass (day 0). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 4. Dynamic rheological properties of hydrogels: A. Elastic moduli (G′) as a function of shear strain (γ*); B. Elastic moduli as a function of frequency (ƒ); C. Viscous
modulus (G″) as a function of frequency, D. Viscosity (η*) as a function of frequency.
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Fig. 5. Cellular behaviour of L929 murine ﬁbroblast
cells cultured at 0.5%, 1%, 2.5% w/v collagen hy-
drogel concentrations and tissue culture plastic (as
control). A. Live/Dead cell membrane staining; B.
Fibroblastic cell morphology by confocal microscopy
after 1 day in culture (Red: phalloidin, Blue: nuclei);
C. DNA content as quantiﬁcation of the total number
of viable cells; D. Metabolic activity normalized to
DNA content per sample on days 1, 3 and 7 of cell
culture on CAF hydrogel surfaces. Data represent
mean values ± SEM (n=3), signiﬁcance threshold
(*p < 0.1, **p < 0.05, ***p < 0.001 and
****p < 0.0001) after two-way ANOVA with
Bonferroni Post-hoc test relative to each type of
sample within and between time points (For inter-
pretation of the references to color in this ﬁgure le-
gend, the reader is referred to the web version of this
article.)
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frequency (ƒ). It can be seen that the elastic moduli (G′) values of all
hydrogels gradually increased with frequency; while viscosity (η*) va-
lues signiﬁcantly decrease with frequency. The elastic moduli (G′) are
larger than the viscous moduli (G″), indicating that CAF hydrogels are
in the solid state, where elastic properties dominate. The viscous
moduli (G″) remained almost constant when the frequency was below
0.1 Hz; after which they increased with frequency. All three hydrogel
formulations show a similar rate of drop in viscosity as frequency in-
creases.
3.2. Response L929 murine ﬁbroblasts to CAF hydrogels
Live/dead staining (Fig. 5.A) demonstrated that the L929 s were
viable with intact cell membrane (green ﬂuorescent cells) and little to
no evidence of dead cells (red ﬂuorescent cells) over a 7-day period. No
signiﬁcant diﬀerences were observed in cell morphology with changing
collagen concentrations (Fig. 5.B). DNA quantiﬁcation (Fig. 5.C) and
normalized Presto Blue reading to DNA content (Fig. 5.D) showed that
the cells were proliferating, but there were no signiﬁcant diﬀerences in
cell number and proliferation rate on the diﬀerent substrates within
each time point.
3.3. Response of pancreatic MIN6 murine β-cells to CAF hydrogels
Large (50–150 μm) aggregates of MIN6 β-cells were observed after
3 days of culture for all concentrations of collagen (Fig. 6.A). However,
higher collagen concentrations led to formation of larger pseudo-islets.
Importantly, larger MIN6 clusters also demonstrated higher levels of
cell death and necrotic core formation; something observed when
clusters outgrow nutrient provision by diﬀusion. Actin and nuclear
cellular staining supported the observations from the Live/Dead ana-
lysis of pseudo-islet formation in MIN6 cells (Fig. 6.B). At day 3, actin
ﬁlament staining illustrated signiﬁcant cell clustering and limited cell
spreading on the surface of the CAF hydrogels. No signiﬁcant diﬀer-
ences in DNA content were observed amongst the MIN6 cells cultured
on the CAF substrates. However, a signiﬁcant increase in DNA content
was found at day 3 on 0.5% collagen hydrogels (Fig. 6.C). The DNA
content was signiﬁcantly higher on tissue culture plastic when com-
pared with CAF hydrogels at days 3 and 7. The MIN6 cells had low
metabolic activity levels at days 1 and 3, with a signiﬁcant increase at
day 7 (Fig. 6.D). Notably, cells seeded on CAF gels with 0.5% collagen
had greater levels of activity than cells on gels made with 1% and 2.5%
collagen at day 7, although initial metabolic activity was signiﬁcantly
higher on the 2.5% collagen gel at day 1.
3.4. Response of human mesenchymal stem cells to CAF hydrogels
Y201 hMSCs were viable when cultured on top of the three collagen
concentrations of CAF hydrogels (Fig. 7.A). The presence of elongated
cells was found to correlate with increasing collagen content in hy-
drogels on day 1 (Fig. 7.B). No signiﬁcant diﬀerences in DNA content
were observed amongst the Y201 cells cultured on the CAF substrates
(Fig. 7.C). Greater cell proliferation was found in all CAF hydrogels
following 7 days of culture. Cells cultured on the CAF hydrogel did not
show any signiﬁcant diﬀerences in terms of metabolic activity at days 3
and 7, but a signiﬁcantly higher metabolic activity was detected on the
0.5% collagen hydrogel compared to the other substrates at day 1
(Fig. 7.D). Notably, a signiﬁcant increase of alkaline phosphatase (ALP)
activity was found in 2.5% collagen hydrogels from day 1 to 7 sug-
gesting an enhanced osteogenic potential with high collagen content
(Fig. 7.E).
4. Discussion
4.1. Physic-chemical and morphological properties of CAF hydrogels
The most relevant peaks of the three components: collagen, alginate
and ﬁbrin were well represented in all the FTIR-ATR spectra of hy-
drogels with 0.5%, 1% and 2.5% collagen (Fig. 1). Downshifts of typical
bands under higher collagen concentrations are attributed to the gra-
dual weakening of speciﬁc molecular interactions, such as hydrogen
bonding and dipole–dipole interactions [51]. Hydrogen bonding in
proteins such as collagen is closely related to interactions between
water and the C]O and NeH groups of the protein backbone [52],
these interactions lower the amide I and amide II intensities [53]. This
eﬀect is closely related to the hydration level of the protein within the
hydrogel. The swelling results showed that hydrogel hydration tends to
decrease with increasing collagen content. This supports the IR results,
which indicate a weakening of hydrogen bonds (established by H2O
molecule interactions with neighbouring molecules) with increasing
collagen concentration. Further analysis, such as nuclear magnetic re-
sonance (NMR) spectroscopy and X-ray photoelectron spectroscopy
(XPS), would support a deeper understanding of the hydrogel chemical
structure. The hydrolytic degradation results show that weakening
hydrogen bonds may impact the hydration degree within the hydrogel
lattice as well as the stability of the hydrogel under physiological
conditions. Hydrogels formulated with higher collagen concentrations
were able to maintain their morphology and mass for 15 days, while
0.5% collagen hydrogels lost about half of their initial mass after 7 days.
With increasing collagen content within CAF hydrogel formulations: 1)
the hydrogen bonds between water and the diﬀerent components of the
gel are weakened; 2) the capacity to retain water within the lattice
decreases; and 3) the hydrogel lattice is stabilized by reducing the
presence of water molecules to break down bonds of the three com-
ponents under physiological conditions.
The gelation time was aﬀected by the amount of collagen protein
since higher concentrations of collagen would favour the kinetic pro-
cess of aggregating collagen molecules at physiological conditions. The
average gelation time was shorter with increasing collagen content
within the hydrogel. This was conﬁrmed by the TEM data as hydrogels
at higher collagen concentrations exhibited a more dense and organized
structure with formation of nano-ﬁbrils [54,55]. CAF hydrogels were
found to be fully degraded and fragmented after 2 h of incubation in
collagenase solution, without signiﬁcant diﬀerences between the for-
mulations. However, the 0.5% collagen hydrogel was the ﬁrst to visibly
degrade and dissolve, which is consistent with collagen playing a key
role in the structural integrity of CAF hydrogels. A quicker enzymatic
degradation through routine procedure for cells isolation represents an
advantage in clinical transplantation, i.e. as islets carrier in diabetic
therapeutic applications.
CAF hydrogels exhibited a porous structure with pore sizes in the
range of 40–120 μm, and the homogeneity of the micro-structure was
shown to decrease with an increasing concentration of collagen. Freeze-
dried hydrogels with 0.5% and 1% collagen showed a more open and
interconnected porous structure than at 2.5% collagen. The closed
micro-pores observed in the freeze-dried hydrogels at the 2.5% collagen
concentration may introduce limitations on nutrient transfer and me-
tabolite diﬀusion within the gels, and may inhibit the formation of neo-
vascular structures following implantation [56,57]. Therefore, de-
pending on the collagen concentration, the CAF hydrogel may be able
to provide a suitable biomaterial for cell culture and tissue engineering
applications; since pore sizes in the 10–150 μm range are normally
identiﬁed in scaﬀolds intended as support for growing and proliferating
cells [58].
The elastic and viscous moduli for all hydrogels showed behaviour
typical of viscoelastic materials [59]. A positive correlation was ob-
served between increasing collagen content and increasing values of
both G′ and G″, with the concentration of collagen in the hydrogel not
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Fig. 6. MIN6 β-cell behaviour on the surface of
CAF hydrogels at diﬀerent collagen concentra-
tions (0.5%, 1%, 2.5% w/v) and tissue culture
plastic as control: A. Live/Dead cell membrane
staining; B. Confocal microscopy of MIN6 β-cells
after 1 day in culture (Red: phalloidin, Blue: nu-
clei); C. Cellular DNA content as measurement of
viable cells per sample; D. Metabolic activity
normalized to DNA content per sample on days 1,
3 and 7 of cell culture. Data represent mean
values± SEM (n=3), signiﬁcance threshold
(*p < 0.1, **p < 0.05, ***p < 0.001 and
****p < 0.0001) after two-way ANOVA with
Bonferroni Post-hoc test relative to each type of
sample within and between time points. (For in-
terpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of
this article.)
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aﬀecting the critical strain. All CAF hydrogel formulations were ob-
served to maintain stable values of G′ and G″, which deﬁned their linear
viscoelastic regime (LVR) up to almost 1% of deformation. For com-
parison, type-I collagen gel has G′ of the order of 10 kPa, alginate gel
has G′ of the order of 100 kPa, and the elastic modulus of soft tissues is
in the range 0.1 to 1000 kPa [15,59]. The three CAF hydrogels have
values ranging from 0.5 to 5 kPa, positioning them at the lower end of
the range for soft tissues, similar to collagen gels. This range is relevant
to many human tissues; for example bulk human pancreatic tissue has
similar values of G′ and G″ to the CAF gels [59].
4.2. Biological response
Murine ﬁbroblast L929 cells have been widely utilised for cytotoxity
and cytocompatibility assays with a variety of materials [60,61]. From
this study, it was observed that the L929 cells seeded on top of the gels
remained viable with no indication of cell death throughout the culture
duration. The diﬀerent concentrations of collagen had no inﬂuence on
the viability, proliferation rate, metabolic activity and morphology of
this cell line.
Research aimed at understanding insulin secretion and β-cell dys-
function in diabetes commonly uses rodent models; since glucose
homeostasis in these animals is similar to humans [62]. MIN6 β-cells
derived from a mouse pancreatic cancer line have the capacity to form
three-dimensional clusters, known as pseudo-islets, which mimic the
structure and function of primary islet β-cells [63,64]. Large
(50–150 μm) aggregates of MIN6 β-cells were observed after day 3 for
all concentrations of collagen investigated; indicating formation of
pseudo-islets. Higher collagen concentrations led to larger pseudo-islets
and increased cell death, as shown by Live/Dead staining. Cell death of
MIN6 β-cells has been found to be upregulated in islet-like spheroid
structures due to the lack of active vascular nutrient delivery into the
spheroids [65]. The formation of larger pseudo-islets in CAF hydrogels
with higher collagen concentrations may result from the key role that
extracellular matrix (ECM) proteins play in regulating β-cell organiza-
tion, survival and insulin secretion [66]. Formulated CAF hydrogel re-
presents a unique platform for tailoring biomimetic microenvironments
to enhance pancreatic β-cells response for treating diabetes type I.
Fig. 7. Cellular behaviour of Y201 cells cultured on CAF hydrogels surfaces at 0.5%, 1%, 2.5% w/v collagen concentrations and tissue culture plastic (as control): A.
Live/Dead cell membrane staining; B. Confocal images Y201 cell morphology after 1 day in culture (Red: phalloidin, Blue: nuclei); C. Cellular DNA content as
measurement of total viable cells; D. Metabolic activity normalized to DNA content; E. Alkaline Phosphatase Activity (ALP) normalized to DNA content after 1, 3 and
7 days in culture. Data represent mean values ± SEM (n=3), signiﬁcance threshold (*p < 0.1, **p < 0.05, ***p < 0.001 and ****p < 0.0001) after two-way
ANOVA with Bonferroni Post-hoc test relative to each type of sample within and between time points. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
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Pseudo-islet formation has been linked to reduced proliferation due
to increased expression of cyclin-dependent kinase inhibitors and down
regulation of ki67 [67]. Here, proliferation was not quantiﬁed ex-
plicitly, but DNA content was similar for most collagen concentrations.
The exceptions were signiﬁcant increases at day 3 with cells on 0.5%
collagen gels and with cells grown on tissue culture plastic. This could
be linked to the formation of smaller pseudo-islets on these substrates
and higher rates of proliferation. Notably, higher levels of MIN6 me-
tabolic activity were found for 1% and 2.5% collagen hydrogels than
the 0.5% collagen hydrogels. Importantly, insulin secretion in trans-
formed β-cells is not inﬂuenced by reduction of proliferation [68]. The
results of this study suggest that CAF hydrogels promote pseudo-islet
formation and metabolic activity in MIN6 β-cells. Furthermore, hy-
drogels with higher concentrations of collagen allow for larger islets to
grow and increase the metabolic activity of the pancreatic cells. This
could be facilitated via up-regulation of cell adhesion molecules and
ECM components in gels containing more collagen.
Y201 hMSCs cultured on the CAF hydrogels with collagen 0.5% and
1% w/v proliferated signiﬁcantly after day 3; but cells cultured on
hydrogels with 2.5% w/v collagen showed no signiﬁcant increase in
proliferation over the same period. However, Y201 cells seeded on the
top of 2.5% w/v collagen CAF hydrogel produced a signiﬁcant increase
in ALP activity after day 3. A lack of cellular proliferation accompanied
by an increase of ALP activity is indicative of osteoblastic diﬀerentia-
tion [69–71]. The enhanced osteogenic potential of Y201 cells on CAF
hydrogels with 2.5% collagen could be due to the high collagen con-
centration and higher material stiﬀness that have been previously
linked to osteogenic diﬀerentiation [72–74]. A common phenomenon
observed for both the L929 and Y201 cell lines seeded on top of the CAF
hydrogels was a decrease in metabolic activity over the course of the
experiment, while cells were still proliferating. This is likely to be the
result of high cell conﬂuency; since results were similar to those for the
tissue culture plastic control.
The formulated tri-component CAF hydrogel has been found to have
a useful range of physical-chemical, mechanical and biological prop-
erties for applications in tissue engineering, cell-therapy, development
of in-vitro models, cell culture and bioprocessing. A comparison be-
tween the CAF hydrogels with potential applications is summarized in
Table 1.
The similarities in terms of viscoelastic properties found between
CAF hydrogels and native soft tissues such as the pancreas and liver,
oﬀers signiﬁcant potential for this hydrogel to be used as a biomaterial
for soft tissue engineering applications, cell-therapy and delivery, cell
culture and bioprocessing for regenerative medicine. For bioprocessing
applications, CAF hydrogels with 0.5% to 1% collagen content may
represent a promising material due to the low viscosity and soft post-
assembly matrix. Both the 0.5% and 1% collagen CAF hydrogels exhibit
a ﬁnal homogeneous structure which mimics the mechanical properties
of a variety of soft tissues as veriﬁed by rheological studies, while still
providing interconnected pores suitable for diﬀusion and exchange of
nutrients and oxygen which may facilitate neovascularization within
3D constructs [75–77]. In contrast, the 2.5% collagen CAF hydrogels
oﬀer potential in applications where stiﬀer matrices are required in
order to guarantee greater mechanical properties and scaﬀold stability
over time. As the 2.5% collagen CAF hydrogel appeared to promote
osteogenic activity of Y201 cells, they may be considered in combina-
tion with structural biomaterials for engineering musculoskeletal tis-
sues.
5. Conclusions
A new thermo-responsive hydrogel based on collagen, alginate, and
ﬁbrin has been synthesized and characterized. CAF hydrogels gel ra-
pidly at physiological conditions, allowing material delivery in the ﬂuid
state at room temperature and subsequent crosslinking at 37 °C. CAF
hydrogels can remain stable for up to 15 days; exhibiting swelling be-
tween 3000 and 4000%, mechanically similar to native soft tissues with
elastic modulus between 0.1 and 1000 kPa, and pore sizes between 40
and 120 μm. Cytocompatibility was demonstrated for three cell lines:
L929 ﬁbroblasts exhibited similar viability and enhanced proliferation
to those cultured on traditional tissue culture plastic; hMSCs showed
enhanced osteogenic potential at higher concentrations of collagen; and
MIN6 β-cells were able to form larger pseudo-islet clusters with a higher
metabolic activity as collagen content increased. CAF hydrogels oﬀer a
tuneable microenvironment that supports cell survival and function for
cell culture applications, and has potential for cell-based regenerative
medicine therapies. Further investigation of this material will consider
speciﬁc applications such as endocrine pancreas tissue engineering and
musculoskeletal applications.
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